TY - JOUR
T1 - Arthroscopic partial meniscectomy for the degenerative meniscus tear
T2 - a comparison of patients included in RCTs and prospective cohort studies
AU - Wijn, Stan R.W.
AU - Hannink, Gerjon
AU - Thorlund, Jonas B.
AU - Sihvonen, Raine
AU - Englund, Martin
AU - Rovers, Maroeska M.
AU - Meniscus IPDMA collaboration group
PY - 2023
Y1 - 2023
N2 - Background and purpose — Concerns exist regarding the generalizability of results from randomized controlled trials (RCTs) evaluating arthroscopic partial meniscectomy (APM) to treat degenerative meniscus tears. It has been suggested that study populations are not representative of subjects selected for surgery in daily clinical practice. There-fore, we aimed to compare patients included in trials and prospective cohort studies that received APM for a degenerative meniscus tear. Patients and methods — Individual participant data from 4 RCTs and 2 cohort studies undergoing APM were collected. 1,970 patients were analyzed: 605 patients included in RCTs and 1,365 included in the cohorts. We compared patient and disease characteristics, knee pain, overall knee function, and health-related quality of life at baseline between the RCT and cohort groups using standardized differences, ratios comparing the variance of continuous covariates, and graphical methods such as quantile–quantile plots, side-by-side boxplots, and non-parametric density plots. Results — Differences between RCT and the cohort were observed primarily in age (younger patients in the cohort; standardized difference: 0.32) and disease severity, with the RCT group having more severe symptoms (standardized difference: 0.38). While knee pain, overall knee function, and quality of life generally showed minimal differences between the 2 groups, it is noteworthy that the largest observed difference was in knee pain, where the cohort group scored 7 points worse (95% confidence interval 5–9, standardized difference: 0.29). Conclusion — Patients in RCTs were largely representative of those in cohort studies regarding baseline scores, though variations in age and disease severity were observed. Younger patients with less severe osteoarthritis were more common in the cohort; however, trial participants still appear to be broadly representative of the target population.
AB - Background and purpose — Concerns exist regarding the generalizability of results from randomized controlled trials (RCTs) evaluating arthroscopic partial meniscectomy (APM) to treat degenerative meniscus tears. It has been suggested that study populations are not representative of subjects selected for surgery in daily clinical practice. There-fore, we aimed to compare patients included in trials and prospective cohort studies that received APM for a degenerative meniscus tear. Patients and methods — Individual participant data from 4 RCTs and 2 cohort studies undergoing APM were collected. 1,970 patients were analyzed: 605 patients included in RCTs and 1,365 included in the cohorts. We compared patient and disease characteristics, knee pain, overall knee function, and health-related quality of life at baseline between the RCT and cohort groups using standardized differences, ratios comparing the variance of continuous covariates, and graphical methods such as quantile–quantile plots, side-by-side boxplots, and non-parametric density plots. Results — Differences between RCT and the cohort were observed primarily in age (younger patients in the cohort; standardized difference: 0.32) and disease severity, with the RCT group having more severe symptoms (standardized difference: 0.38). While knee pain, overall knee function, and quality of life generally showed minimal differences between the 2 groups, it is noteworthy that the largest observed difference was in knee pain, where the cohort group scored 7 points worse (95% confidence interval 5–9, standardized difference: 0.29). Conclusion — Patients in RCTs were largely representative of those in cohort studies regarding baseline scores, though variations in age and disease severity were observed. Younger patients with less severe osteoarthritis were more common in the cohort; however, trial participants still appear to be broadly representative of the target population.
U2 - 10.2340/17453674.2023.24576
DO - 10.2340/17453674.2023.24576
M3 - Article
C2 - 38037388
AN - SCOPUS:85178929803
SN - 1745-3674
VL - 94
SP - 570
EP - 576
JO - Acta Orthopaedica
JF - Acta Orthopaedica
ER -